ARCELLX
Arcellx is a clinical-stage biotechnology company reimagining cell therapy by engineering innovative immunotherapies for patients with cancer and other incurable diseases. Arcellx believes that cell therapies are one of the forward pillars of medicine and Arcellx’s mission is to advance humanity by developing cell therapies that are safer, more effective, and more broadly accessible. Arcellx’s lead product candidate, CART-ddBCMA, is being developed for the treatment of relapsed or refractory... multiple myeloma (r/r MM) in an ongoing Phase 1 study. CART-ddBCMA has been granted Fast Track, Orphan Drug, and Regenerative Medicine Advanced Therapy designations by the U.S. Food and Drug Administration. Arcellx is also advancing its dosable and controllable CAR-T therapy, ARC-SparX, into the clinic through two programs: ACLX-001 in r/r MM and ACLX-002 in relapsed or refractory acute myeloid leukemia.
ARCELLX
Industry:
Biopharma Biotechnology Health Care Life Science Pharmaceutical
Founded:
2015-01-01
Address:
Gaithersburg, Maryland, United States
Country:
United States
Website Url:
http://www.arcellx.com
Total Employee:
101+
Status:
Active
Total Funding:
622 M USD
Technology used in webpage:
Domain Not Resolving Google Maps Amazon HSTS IPv6 U.S. Server Location Amazon Virginia Region GoDaddy SSL Comcast Q4Web Hosting
Similar Organizations
Antheia
A synthetic biology company for next generation plant-inspired medicines
Athelas
Athelas develops technology to monitor chronically ill patients in their homes.
Avidity Biosciences
Avidity Biosciences is a biotechnology company that develops oligonucleotide-based therapies for its patients.
Capital Rx
Capital Rx is a healthtech platform that provides pharmacy benefit management solutions.
Capsule
Capsule is a healthcare technology business rebuilding the pharmacy from the inside out
Cleo
Cleo is a benefits platform that provides personalized guidance for working families.
Resilience
Resilience provides end-to-end biopharmaceutical manufacturing and development solutions.
Trevena
Trevena is a clinical stage biopharmaceutical company discovering and developing G-protein coupled receptors (GPCR) biased ligands.
Twist Bioscience
Twist Bioscience is a synthetic DNA production for specialty chemical compounds and drug development.
Zealand Pharma
Zealand Pharma is a biotechnology company that offers scientific expertise in turning peptides into medicines.
Current Advisors List
Board_member
Board_member
Board_observer
2021-05-01
Current Employees Featured
Michelle Gilson Chief Financial Officer @ Arcellx
Chief Financial Officer
2022-05-01
David Kim Head Of Supply Chain @ Arcellx
Head Of Supply Chain
2021-05-01
Christopher Heery Chief Medical Officer @ Arcellx
Chief Medical Officer
2021-04-01
David Hilbert President and CEO @ Arcellx
President and CEO
Brad Gliner Vice President, Clinical Research and Regulatory Affairs @ Arcellx
Vice President, Clinical Research and Regulatory Affairs
2021-03-01
Brian Murphy VP Cell Process Science @ Arcellx
VP Cell Process Science
2020-08-01
Founder
Stock Details
Investors List
Kite Pharma
Kite Pharma investment in Post-IPO Equity - Arcellx
Kite Pharma
Kite Pharma investment in Post-IPO Equity - Arcellx
Suvretta Capital Management
Suvretta Capital Management investment in Series C - Arcellx
Terra Magnum Capital Partners (""""TMCP"""")""
Terra Magnum Capital Partners (""""TMCP"""")"" investment in Series C - Arcellx
LG Technology Ventures
LG Technology Ventures investment in Series C - Arcellx
Novo Holdings
Novo Holdings investment in Series C - Arcellx
CaaS Capital Management
CaaS Capital Management investment in Series C - Arcellx
Adage Capital Management
Adage Capital Management investment in Series C - Arcellx
Soleus Capital
Soleus Capital investment in Series C - Arcellx
Clough Capital Partners
Clough Capital Partners investment in Series C - Arcellx
Key Employee Changes
| Date | New article |
|---|---|
| 2022-05-23 | Arcellx Names Michelle Gilson as New CFO |
Official Site Inspections
http://www.arcellx.com Semrush global rank: 2.04 M Semrush visits lastest month: 10.16 K
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Arcellx"
Our Company, Story, and Leadership Team - Arcellx
Arcellx is a biotechnology company dedicated to advancing humanity by engineering cell therapies that are safer, more effective, and broadly accessible. ... The organization also managed external audits and inspections by their …See details»
Arcellx Cell Therapies for Cancer and Autoimmune Diseases
Reimagining cell therapy. Powered by our novel D-Domain technology and paired with our transformative ddCAR and ARC-SparX platforms, our unique approach to cell therapy aims to …See details»
Arcellx - Crunchbase Company Profile & Funding
Arcellx is a clinical-stage biotechnology company reimagining cell therapy by engineering innovative immunotherapies for patients with cancer and other …See details»
Investor Relations - Arcellx
Feb 26, 2025 Arcellx, Inc. (NASDAQ: ACLX) is a clinical-stage biotechnology company reimagining cell therapy by engineering innovative immunotherapies for patients with cancer …See details»
Arcellx | VaLogic
Dec 12, 2024 Organization through a collaborative and challenging work environment, makes VaLogic a great place …See details»
Arcellx - The Org
Arcellx is a clinical-stage biopharmaceutical company developing novel, adaptive and controllable cell therapies for the treatment of patients with cancer and autoimmune diseases. Industries. …See details»
Arcellx - Contacts, Employees, Board Members, Advisors & Alumni
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies. New. Resources. ... Experience the new Crunchbase, powered by AI . Experience …See details»
Arcellx - Funding, Financials, Valuation & Investors - Crunchbase
Arcellx is registered under the ticker NASDAQ:ACLX . Their stock opened with $16.00 in its Feb 4, 2022 IPO. Stock Symbol NASDAQ:ACLX ; Valuation at IPO $503.1M; Money Raised at IPO …See details»
Arcellx Company Profile | Management and Employees List
Arcellx is a clinical-stage biopharmaceutical company developing adaptive and controllable cell therapies for the treatment of patients with cancer and autoimmune diseases. The Arcellx …See details»
Governance - Committee Composition - Arcellx
At Arcellx, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting …See details»
Arcellx Announces Executive Appointments
The Arcellx vision is to utilize our novel proprietary platform to bring superior cell therapies to more patients through the care of academic and community practices worldwide. More …See details»
Working at Arcellx - Great Place To Work®
Arcellx, Inc. is a clinical-stage biotechnology company reimagining cell therapy by engineering innovative immunotherapies for patients with cancer and other incurable diseases. We believe …See details»
20 Things You Didn’t Know About Arcellx - Money Inc
Feb 19, 2022 Arcellx is a biotechnology business. It specializes in developing and production of clinical-stage superior immune therapies for cancer patients and those. ... Lewis Williams, also …See details»
Arcellx, Inc.: history, ownership, mission, how it works & makes …
[relinking] Home History Owners Mission How It Works How It Makes Money A Brief History of Arcellx, Inc. Arcellx, Inc., founded in 2014, is a clinical-stage biotechnology company focused …See details»
Arcellx Appoints Andrew Galligan and Kristin Myers to Its Board of ...
REDWOOD CITY, Calif., March 20, 2025--Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for …See details»
Arcellx - Work in biotech
Arcellx is developing immunotherapies to treat cancer. Chimeric antigen receptor (CAR) T-cells are the latest innovation to identify and eliminate cancer cells, yet there is still more room for …See details»
What is Arcellx? Company Culture, Mission, Values | Glassdoor
Arcellx was founded in 2014 with the goal of adding control and adaptability to the potential of cell therapy. In February, 2020, the first patient was dosed with CART-ddBCMA for the treatment …See details»
Arcellx Company Profile - Office Locations, Competitors ... - Craft
Oct 29, 2024 Arcellx has 1 employees at their 1 location and $107.94 m in annual revenue in FY 2024. See insights on Arcellx including office locations, competitors, revenue, financials, …See details»
Mission, Vision & Core Values of Arcellx – CANVAS, SWOT, PESTEL …
Nov 30, 2024 Collaboration is key to our success at Arcellx. We foster a culture of teamwork, open communication, and mutual respect, both within our organization and with external …See details»
Arcellx Appoints Andrew Galligan and Kristin Myers to Its Board of ...
Mar 20, 2025 Arcellx believes that cell therapies are one of the forward pillars of medicine and Arcellx's mission is to advance humanity by developing cell therapies that are safer, more …See details»